ReShape Lifesciences Balance Sheet Health
Financial Health criteria checks 4/6
ReShape Lifesciences has a total shareholder equity of $20.9M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $28.5M and $7.5M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$6.15m |
Equity | US$20.94m |
Total liabilities | US$7.51m |
Total assets | US$28.46m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 24O's short term assets ($13.6M) exceed its short term liabilities ($7.5M).
Long Term Liabilities: 24O has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: 24O is debt free.
Reducing Debt: 24O had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 24O has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 24O has less than a year of cash runway if free cash flow continues to grow at historical rates of 8.2% each year.